Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

NACompletedINTERVENTIONAL
Enrollment

1,056

Participants

Timeline

Start Date

July 29, 2020

Primary Completion Date

May 20, 2022

Study Completion Date

May 24, 2022

Conditions
COVID-19 Infection
Interventions
BIOLOGICAL

serology test

volume according to child weight

BIOLOGICAL

nasopharyngeal swab

nasopharyngeal swab for PCR

BIOLOGICAL

rectal swab

rectal swab for PCR

BIOLOGICAL

saliva sample

for biocollection

Trial Locations (1)

75015

Hôpital necker Enfants-Malades, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Commissariat A L'energie Atomique

OTHER_GOV

collaborator

Institut Pasteur

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04355533 - Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 | Biotech Hunter | Biotech Hunter